Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma

OBJECTIVE: Gastric adenocarcinoma (GAC) is the third most common cause of cancer mortality worldwide. Accurate and affordable non-invasive detection methods have potential value for screening and surveillance. Herein, we identify novel methylated DNA markers (MDMs) for GAC, validate their discrimina...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Cancer Res
Auteurs principaux: Anderson, Bradley W., Suh, Yun-Suhk, Choi, Boram, Lee, Hyuk-Joon, Yab, Tracy C., Taylor, William R., Dukek, Brian A., Berger, Calise K., Cao, Xiaoming, Foote, Patrick H., Devens, Mary E., Boardman, Lisa A., Kisiel, John B., Mahoney, Douglas W., Slettedahl, Seth W., Allawi, Hatim T., Lidgard, Graham P., Smyrk, Thomas C., Yang, Han-Kwang, Ahlquist, David A.
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6239895/
https://ncbi.nlm.nih.gov/pubmed/29844130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-3364
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires